Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Cyril P. Clarke"'
Autor:
Rafael D. Escandon, Khalil G. Saikali, Mohammad R. Habibzadeh, Jacqueline H. Lee, Cyril P. Clarke, Jonathan H. Goldman, Michael M. Chen, John R. Teerlink, Fady I. Malik, Lyndsey Elliott, Nelson B. Schiller, Andrew A. Wolff, Rachel Bee
Publikováno v:
The Lancet. 378:667-675
Decreased systolic function is central to the pathogenesis of heart failure in millions of patients worldwide, but mechanism-related adverse effects restrict existing inotropic treatments. This study tested the hypothesis that omecamtiv mecarbil, a s
Autor:
Märta Segerdahl, Karin Huizar, Cyril P. Clarke, Jarkko Kalliomäki, Peter Annas, Rolf Karlsten, Annika Zettergren
Publikováno v:
Clinical and experimental pharmacologyphysiology. 40(3)
Summary The aim of the present study was to investigate the effects of AZD1940, a novel peripherally acting cannabinoid CB1/CB2 receptor agonist, on capsaicin-induced pain and hyperalgesia, as well as on biomarkers of cannabinoid central nervous syst
Autor:
Darrel P. Francis, Ludwig Neyses, Chim C. Lang, Jamil Mayet, Andrew A. Wolff, Roxy Senior, John Murray, John R. Teerlink, Fady I. Malik, Jonathan H. Goldman, Mitchell T. Saltzberg, Barry H. Greenberg, Vitaly A. Tsyrlin, Mark J. Monaghan, Cyril P. Clarke, Evgeny M. Nifontov, Jacqueline H. Lee, John G.F. Cleland, Tamaz Shaburishvili, Scott M. Wasserman, Khalil G. Saikali
Background: Many patients with heart failure remain symptomatic and have a poor prognosis despite existing treatments. Decreases in myocardial contractility and shortening of ventricular systole are characteristic of systolic heart failure and might
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa99c2c5e061ae2c3857a9ccf20ee531
https://acuresearchbank.acu.edu.au/item/88q4w/the-effects-of-the-cardiac-myosin-activator-omecamtiv-mecarbil-on-cardiac-function-in-systolic-heart-failure-a-double-blind-placebo-controlled-crossover-dose-ranging-phase-2-trial
https://acuresearchbank.acu.edu.au/item/88q4w/the-effects-of-the-cardiac-myosin-activator-omecamtiv-mecarbil-on-cardiac-function-in-systolic-heart-failure-a-double-blind-placebo-controlled-crossover-dose-ranging-phase-2-trial
Autor:
Gavin Brown, Stefan Bradley, Cyril P Clarke, Andrew W Philipp, Peter S. Talbot, Adam McMahon, Kola O Babalola, Julian C. Matthews
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 35(3)
Sibutramine is a centrally acting monoamine reuptake inhibitor prescribed as an appetite suppressant in the management of obesity. Its effects are mostly attributable to serotonin and norepinephrine transporter (SERT and NET, respectively) inhibition
Autor:
Cyril P. Clarke, V.A. Tsyrlin, Chim C. Lang, Jamil Mayet, Andrew A. Wolff, Mark J. Monaghan, G. Brand, Darrel P. Francis, Barry H. Greenberg, Ludwig Neyses, Jonathan H. Goldman, Jacqueline H. Lee, John J.V. McMurray, John R. Teerlink, Fady I. Malik, Roxy Senior, John G.F. Cleland, E.M. Nifontov, Khalil G. Saikali
Publikováno v:
Journal of Cardiac Failure. 14:797-798
Autor:
Cyril P. Clarke, Jonathan H. Goldman, John G.F. Cleland, Chim C. Lang, John J.V. McMurray, Khalil G. Saikali, John R. Teerlink, Fady I. Malik, Jacqueline H. Lee, Ludwig Neyses
Publikováno v:
European Journal of Heart Failure Supplements. 7:189-190
Publikováno v:
Journal of Cardiac Failure. 13:S145-S146
Autor:
Markus Jerling, Cyril P. Clarke, Rafael D. Escandon, Ester Venables, Fady I. Malik, Andrew A. Wolff, Jacqueline H. Lee, Terence Chew
Publikováno v:
Journal of Cardiac Failure. 13:S148
Autor:
Andrew A. Wolff, Jacqueline H. Lee, Cyril P. Clarke, Khalil G. Saikali, Rafael D. Escandon, John R. Teerlink, Fady I. Malik
Publikováno v:
Journal of Cardiac Failure. 12:763